100% Quality Guarantee
PhD-Level Technical Support
Human Glycoprotein Ib Alpha Polypeptide,Platelet GP1Ba ELISA Kit
Key Features

Human Glycoprotein Ib Alpha Polypeptide,Platelet (GP1Ba) ELISA Kit (HUDL01224)

SKU HUDL01224
Product Type ELISA Kit
Size 96 Assays
Uniprot P07359
Sensitivity 0.63ng/mL
Range 1.56-100ng/mL
ELISA Type Sandwich
Synonyms CD42b,CD42-B,CD42b-Alpha,GP1-BA,BSS,GP1B,GPIBA,Glycocalicin
Reactivity Human
Sample Type Serum, Plasma And Other Biological Fluids
$986

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Human Glycoprotein Ib Alpha Polypeptide,Platelet (GP1Ba) ELISA Kit

The Human Platelet Glycoprotein Ib Alpha (GP1BA) ELISA Kit is a highly sensitive and specific assay designed for the detection of GP1BA levels in human serum, plasma, and cell culture supernatants. This kit provides accurate and reproducible results, making it suitable for a variety of research applications.Glycoprotein Ib Alpha is a key component of platelet function, playing a crucial role in adhesion to injured blood vessels and initiation of clot formation.

Abnormalities in GP1BA have been associated with various bleeding disorders and cardiovascular diseases, highlighting its importance as a potential biomarker.With its robust performance and broad applicability, the Human GP1BA ELISA Kit is an invaluable tool for studying platelet function, investigating bleeding disorders, and exploring potential therapeutic targets for cardiovascular diseases.

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose